Latest filing published 18 Aug 2023 for Eris Lifesciences Limited, €18k.
Filing timeline
BuySaleSabyasachi Sharma: trading record in brief
Sabyasachi Sharma, listed as chief executive, appears in our data through filings on Eris Lifesciences Limited shares, published by SEBI (PIT + SAST). In total, 6 filings cover trades dated from 22 June 2021 to 17 August 2023.
Every open-market trade on record is a sale: 4 sales worth €109k. Other entries cover 2 share grants. So far in 2023, the count stands at no purchases and 1 sale.
The newest entry dates from 18 August 2023: an open-market sale of €18k, in Eris Lifesciences Limited. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sabyasachi Sharma
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ ₹795.7469.6% of flowEquity SharesSEBI:62608f139024f5fd96621b07791fc7ca8adc15da
- 4,990 shares@ ₹451.039914.9% of flowEquity SharesSEBI:09f11cbe747419e4007a0a8de5b4968e6417f8c1Canonical exit: 19 Sept 2022 (T+90)
- 3,000 shares@ ₹713.266714.2% of flowEquity SharesSEBI:49cc0e2047ddc09142f21770fd771716b2bb12f4
- 3,463 shares@ ₹734.52670.0000% mcap100.0% of flowEquity SharesSEBI:218220370e814cc284daaf1558dbc8532220474b
- 14,965 shares@ ₹451.040.0000% mcap68.2% of flowEquity SharesSEBI:618a6bf218f3fe8e21ecd193830475d4a43ca68dCanonical exit: 11 Oct 2021 (T+90)
- 4,500 shares@ ₹707.17530.0000% mcap31.8% of flowEquity SharesSEBI:f4e9bf8eb763b553f09f3411d9ad46fe6253bd3d
6 of 6 declarations